CompoAtlas

larityMD Clear Skin Formula

Natural health product licensed in Canada

Other names
Skin Clarifying Acne Pads
Licence holder
Envy Medical Inc.
NPN or DIN-HM
80073682
Status
Active licence
Licence date
9 November 2016
Revision date
Not provided
Form
Serviette, traité
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Acide 2-hydroxybenzoïque

Source : Acide salicylique

2 Pour cent

Non-medicinal ingredients

Aqua, Parfum, Jus de feuilles d'Aloe Barbadensis, Menthol, Stéarate de PEG-30 glycéryle, Lauryl glucoside, Extrait d'écorce/ de Feuilles/ de branches de Hamamelis Virginiana (hamamélis), Stéarate de glycéryle, Phénoxyéthanol, Borate de sodium, EDTA de sodium, Lauryl Glucose Carboxylate de Sodium, citrate de sodium, Acide citrique, PPG-5-Ceteth-20, simethicone, Caprylyl Glycol

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

For the treatment/management of acne.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80073682

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line